The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 131 (5), 631-635
- https://doi.org/10.1016/s0002-9394(00)00902-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Safety and Efficacy of Switching Timolol Maleate 0.5% Solution to Timolol Hemihydrate 0.5% Solution Given Twice DailyJournal of Ocular Pharmacology and Therapeutics, 1998
- A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular HypertensionOphthalmology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Effects on Intraocular Pressure and Side Effects of 0.005% Latanoprost Applied Once Daily, Evening or MorningOphthalmology, 1995
- Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human EyesOphthalmology, 1993
- Phenyl substituted prostaglandin analogs for glaucoma treatmentDrugs of the Future, 1992
- Prostaglandin F2α increases uveoscleral outflow in the cynomolgus monkeyExperimental Eye Research, 1989
- Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2α-1-isopropylester in the cynomolgus monkeyExperimental Eye Research, 1989
- Prostaglandin F2α-1-Isopropylester Lowers Intraocular Pressure Without Decreasing Aqueous Humor FlowAmerican Journal of Ophthalmology, 1988
- A double‐masked crossover study comparing the effects of carteolol 1% and 2% on intra‐ocular pressureActa Ophthalmologica, 1987